Pfizer Soars After Covid Pill Shows Strong Results in Study (1)

Pfizer Inc. said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%, a result that has the potential to upend how the disease caused by the coronavirus is treated and alter the course of the pandemic. The shares surged.

The drugmaker said in a statement on Friday that it was no longer taking new patients in a clinical trial of the treatment “due to the overwhelming efficacy” and planned to submit the findings to U.S. regulatory authorities for emergency authorization as soon as possible.

WATCH: Pfizer CEO Albert Bourla discusses the manufacturing and distribution plans for its Covid-19 pill.

Source: Bloomberg

The results mean there are now two promising candidates for treating Covid-19 ...